Dr. Joseph Fraiman

speaker
522 appearances 2 recordings 1 series first heard Dec 2025 last heard 4 Sep

Dr. Joseph Fraiman’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Sep OctJan 26AprJulnow

Recordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.

Appearances

newest first · ▶ plays the moment
There, you know, it's been recommended on a public health level.
So saying that it's going to reduce hospitalizations and reduce death from the flu.
Yet we didn't, we still to this day do not have trials showing Tama flu is reducing death and and hospitalization.
I know there's a large meta-analysis that looked at at this question for hospitalization, saying, no, we don't see.
there's not clear evidence that it's reducing hospitalization, a a clinical trial is needed.
So I think that you know when we're saying before what is public health and their purpose because Tamouflu, what we do know it does is it
It seems to reduce symptomatology for symptoms for, you know, a small difference in symptoms.
tra it's a trade off.
You know, you get a a shortening of your seven hour seven day flu, maybe by sixteen hours.
That seems pretty
Pretty real.
It does reduce your symptoms.
Trade it's a trade off for a risk of diarrhea.
And vomiting.
So so like there's two different things when we think about a a thing like Tamaflu.
One is like, do you w are you taking this drug to feel less icky?
Or are you taking this drug to prevent hospitalization and death?
And and I don't I I feel like these things can't sometimes be mixed together and those aren't the same question.
And you know, we we as physicians.
Not
Showing 161–180 of 522 · page 9 of 27 ← Previous Next →